article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

Cipla Vs Sun Pharmaceutical : Pharma companies bear enormous responsibility for producing medicines and monetizing the time and effort spent on research and development for years by using patent protection. Sun Pharma’s portfolio includes innovative specialty medicines, branded generics, pure generics, and APIs.

article thumbnail

Fundamental Analysis Of Lupin – Industry Analysis and Financials

Trade Brains

Fundamental Analysis Of Lupin : Medicines are substances that can be used to prevent, treat, or cure disease. Pharmaceutical companies in India have come a long way in supplying medicines, and with more research, they are improving their products. Segment Analysis The company’s revenue was Rs. crore in FY23.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis Of Zydus Lifesciences – Financials & More Details

Trade Brains

Industry Overview India is the 12th-largest market in terms of value and the world’s third-largest pharmaceutical manufacturer in terms of volume. The Indian pharmaceutical sector includes over-the-counter medicines, generic medications, bulk drugs, vaccines, contract research and manufacture, biosimilars, and biologics.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. As per IQVIA report, the global medicine market is expected to reach USD 1.9

article thumbnail

Best Dividend Stocks Under Rs 1000 – Analysis & Top Picks

Trade Brains

Best Dividend Stocks Under Rs 1000 #3 – Novartis India Novartis India Limited is a subsidiary of Novartis AG, a leading global medicines company.

article thumbnail

High FII Holding Stocks Under Rs 500 To Add To Your Watchlist

Trade Brains

Net profit has decreased due to an increase in fixed-cost expenses such as employee costs and the purchase of medicines and consumables. Market Cap (Cr.) ₹ 19,963 RoE (%) 11.32% RoCE (%) 14.36% P/E (TTM) 61.4 The company’s net profits were Rs. crore in FY23, up from Rs. crore in FY22, a -20.95% decrease. Price to Book Value 3.99

article thumbnail

Best Mid Cap Chemical Stocks in India To Add To Your Watchlist

Trade Brains

The Basic Chemistry product line of the company supplies critical ingredients to many of the world’s leading brands in glass, detergents, medicines, biscuit making, bakeries, and other industries. The company is divided into two segments: basic chemistry products and specialty products.